Tsubota LaboratoryTsubota Laboratory Incorporated4890東証グロースサービス業FY ending Mar 2026, non-consolidated, J-GAAP

Tsubota Laboratory revenue and profit

It lost about ¥394 for every ¥100 of sales at the operating level. Revenue changed -85.3% from the prior year, operating profit -434.6%.

Five-year trend

Revenue¥200M
FY ending Mar 2022: ¥640.9M¥640.9MFY ending Mar 2023: ¥954.7M¥954.7MFY ending Mar 2024: ¥673.5M¥673.5MFY ending Mar 2025: ¥1.36B¥1.36BFY ending Mar 2026: ¥200M¥200MFY22FY23FY24FY25FY26
Operating income-¥787.8M
FY ending Mar 2022: ¥136.2M¥136.2MFY ending Mar 2023: ¥167M¥167MFY ending Mar 2024: -¥649.6M-¥649.6MFY ending Mar 2025: ¥235.5M¥235.5MFY ending Mar 2026: -¥787.8M-¥787.8MFY22FY23FY24FY25FY26
Operating margin-393.9%
FY ending Mar 2022: 21.2%21.2%FY ending Mar 2023: 17.5%17.5%FY ending Mar 2024: -96.4%-96.4%FY ending Mar 2025: 17.4%17.4%FY ending Mar 2026: -393.9%-393.9%FY22FY23FY24FY25FY26

What drives ROE

Net margin × asset turnover = ROA; ROA × financial leverage = ROE

Net margin—
2022: 23.9%23.9%2023: 9.4%9.4%2025: 15.2%15.2%2223242526
Asset turnover—
2022: 0.40×0.40×2023: 0.44×0.44×2025: 0.57×0.57×2223242526
ROA-39.9%
2022: 9.5%9.5%2023: 4.2%4.2%2024: -25.8%-25.8%2025: 8.6%8.6%2026: -39.9%-39.9%2223242526
Financial leverage—
2022: 2.17×2.17×2023: 1.59×1.59×2025: 1.62×1.62×2223242526
ROE—
2022: 20.6%20.6%2023: 6.7%6.7%2025: 13.9%13.9%2223242526
PeriodNet marginAsset turnoverROAFinancial leverageROE
202223.9%0.40×9.5%2.17×20.6%
20239.4%0.44×4.2%1.59×6.7%
2024——×-25.8%—×—
202515.2%0.57×8.6%1.62×13.9%
2026——×-39.9%—×—

Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.

Asset intensity and goodwill

Annual trends in tangible-asset ratios and goodwill balance.

PPE ÷ revenue13.6%
2021: 6.7%6.7%2022: 11.0%11.0%2023: 8.2%8.2%2024: 7.8%7.8%2025: 3.2%3.2%2026: 13.6%13.6%212223242526
PPE ÷ total assets2.1%
2021: 4.3%4.3%2022: 4.4%4.4%2023: 2.9%2.9%2024: 2.3%2.3%2025: 1.8%1.8%2026: 2.1%2.1%212223242526

Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition

Investment and working-capital efficiency

Track R&D investment and how long operating capital remains tied up before sales turn into cash.

R&D spending¥279.5M
2022: ¥117M¥117M2023: ¥126.3M¥126.3M2024: ¥205.3M¥205.3M2025: ¥254.1M¥254.1M2026: ¥279.5M¥279.5M212223242526
R&D / revenue139.7%
2022: 18.3%18.3%2023: 13.2%13.2%2024: 30.5%30.5%2025: 18.7%18.7%2026: 139.7%139.7%212223242526

R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.

Income statement (JPY millions)

ItemFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Revenue6419556741,357200
Cost of revenue8423665218068
Gross profit557719211,177132
SG&A421552671941919
Operating income136167-650235-788
Pretax income202144-636281-761
Income tax49545751
Net income attributable to owners15390-641206-762
Operating margin21.2%17.5%-96.4%17.4%-393.9%

Balance sheet (reported items)

Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.

Assets

Cash 74%
2%
0%
Other assets 24%

Funding

Other liabilities 34%
Equity 66%
0%

Each bar totals 100% of assets; other is the residual.

ItemFY ending Mar 2022FY ending Mar 2023FY ending Mar 2024FY ending Mar 2025FY ending Mar 2026
Cash and equivalents¥1.17B¥2.16B¥1.88B¥1.54B¥969.8M
Total assets¥1.62B¥2.67B¥2.3B¥2.5B¥1.32B
Net assets¥744.4M¥1.95B¥1.37B¥1.59B¥863.9M
Share capital¥231.1M¥789M¥818.1M¥825.2M¥844.4M
Property, plant and equipment¥70.7M¥77.9M¥52.7M¥44M¥27.2M
Intangible assets excluding goodwill¥15.1M¥11.5M¥8.8M¥6.8M¥5M
Current assets¥1.52B¥2.57B¥2.22B¥2.45B¥1.28B
Current liabilities¥674.1M¥607.7M¥837.5M¥846.6M¥408M
Long-term borrowings¥199.3M¥114.9M¥90.4M¥69.2M¥46.9M
Total liabilities¥873.4M¥722.6M¥927.9M¥915.9M¥454.9M
Equity attributable to owners of parent¥744.4M¥1.95B¥1.37B¥1.59B¥863.9M
Retained earnings¥298.2M¥388.4M-¥252.9M-¥47.1M-¥808.9M

Sources

Show source documents (5)
  • EDINET (FSA Japan)

    有価証券報告書-第14期(2025/04/01-2026/03/31)

    ID S100YFH92026-06-19Open
  • EDINET (FSA Japan)

    有価証券報告書-第13期(2024/04/01-2025/03/31)

    ID S100W7HJ2025-06-26Open
  • EDINET (FSA Japan)

    有価証券報告書-第12期(2023/04/01-2024/03/31)

    ID S100TO2G2024-06-27Open
  • EDINET (FSA Japan)

    有価証券報告書-第11期(2022/04/01-2023/03/31)

    ID S100R4M32023-06-29Open
  • EDINET (FSA Japan)

    訂正有価証券報告書-第10期(令和3年4月1日-令和4年3月31日)

    ID S100OYG22022-08-10Open

Extracted from XBRL: 39 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.